MeiraGTx Holdings (MGTX) Free Cash Flow (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Free Cash Flow of $46.4 million for Q4 2025, up 461.47% on a QoQ basis from -$12.8 million in Q3 2025, and up 289.27% year-over-year from $11.9 million in Q4 2024.
MeiraGTx Holdings (MGTX) Free Cash Flow (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Free Cash Flow history runs 9 years deep, the most recent figure standing at $46.4 million for Q4 2025.
- Quarterly Free Cash Flow rose 289.27% year-over-year to $46.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$50.2 million (up 54.15% YoY) and the FY2025 annual result came in at -$50.2 million, up 54.15% from the prior year.
- Free Cash Flow was $46.4 million for Q4 2025 at MeiraGTx Holdings, up from -$12.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $46.4 million in Q4 2025 and bottomed at -$61.1 million in Q4 2022.
- A 5-year average of -$22.1 million and a median of -$25.1 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 1003.03% — and 2025, when it surged 289.27%.
- MeiraGTx Holdings' Free Cash Flow stood at -$5.5 million in 2021, then slumped by 1003.03% to -$61.1 million in 2022, then soared by 73.26% to -$16.3 million in 2023, then tumbled by 49.89% to -$24.5 million in 2024, then jumped by 289.27% to $46.4 million in 2025.
- Business Quant data shows MGTX's Free Cash Flow at $46.4 million in Q4 2025, -$12.8 million in Q3 2025, and -$45.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 46.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.36 Mn |
| Dec 31, 2025 | 46.36 Mn |
| Sep 30, 2025 | -12.83 Mn |
| Sep 30, 2025 | -12.83 Mn |
| Jun 30, 2025 | -45.21 Mn |
| Jun 30, 2025 | -45.21 Mn |
| Mar 31, 2025 | -38.51 Mn |
| Mar 31, 2025 | -38.51 Mn |
| Dec 31, 2024 | -24.49 Mn |
| Dec 31, 2024 | -24.49 Mn |
| Sep 30, 2024 | -25.75 Mn |
| Sep 30, 2024 | -25.75 Mn |
| Jun 30, 2024 | -23.10 Mn |
| Jun 30, 2024 | -23.10 Mn |
| Mar 31, 2024 | -36.11 Mn |
| Mar 31, 2024 | -36.11 Mn |
| Dec 31, 2023 | -16.34 Mn |
| Dec 31, 2023 | -16.34 Mn |
| Sep 30, 2023 | -10.85 Mn |
| Sep 30, 2023 | -10.85 Mn |